Abstract
Chronic acid retention is known to promote bone dissolution. In this study, 23 % of patients with osteopenia/osteoporosis were diagnosed with abnormal distal renal tubular acidification (dRTA), a kidney dysfunction leading to chronic acid retention. Treating those patients with alkali-therapy shows improvement in bone density. To evaluate the prevalence of abnormal distal renal tubular acidification in patients with low bone mass (LBM) and the impact of additional alkali treatment on bone density in patients with concomitant LBM and dRTA,183 patients referred for metabolic evaluation of densitometrically proven low bone mass were screened for abnormal distal renal tubular acidification between 2006 and 2013. In all LBM urine pH (U-pH) was measured in the 2nd morning urines after 12 h of fasting. If U-pH was ≥5.80, LBM underwent a 1-day ammonium chloride loading, and U-pH was remeasured the next morning. If U-pH after acid loading did not drop below 5.45, patients were diagnosed with abnormal distal renal tubular acidification. Normal values were obtained from 21 healthy controls. All LBM with dRTA were recommended alkali citrate in addition to conventional therapy of LBM, and follow-up DXAs were obtained until 2014. 85 LBM underwent NH4Cl loading. 42 LBM patients were diagnosed with incomplete dRTA (idRTA; prevalence 23.0 %). During follow-up (1.6–8 years) of idRTA-LBM patients, subjects adhering to alkali treatment tended to improve BMD at all sites measured, whereas BMD of non-adherent idRTA patients worsened/remained unchanged. (1) About one out of four patients with osteopenia/osteoporosis has idRTA. (2) Upon NH4Cl loading, idRTA patients do not lower urine pH normally, but show signs of increased acid-buffering by bone dissolution. (3) In idRTA patients with low bone mass on conventional therapy, additional long-term alkali treatment improves bone mass at lumbar spine and potentially at other bone sites. (4) All patients with low bone mass undergoing metabolic evaluation should be screened for idRTA.
Similar content being viewed by others
References
Eiam-Ong S, Kurtzman NA (1994) Metabolic acidosis and bone disease. Miner Electrolyte Metab 20:72–80
Bushinsky DA (2002) Integration of calcium metabolism in the adult. In: Coe FL, Favus MJ (eds) Disorders of bone and mineral metabolism, 2nd edn. Lippincott, Philadelphia, pp 381–396
Krieger NS, Sessler NE, Bushinsky DA (1992) Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro. Am J Physiol 262:F442–F448
Maurer M, Riesen W, Muser J, Hulter HN, Krapf R (2003) Neutralization of western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol 284:F32–F40
Sebastian A, Harris ST, Ottaway JH, Todd KM, Morris jr RC (1994) Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med 330:1776–1781
Gluck SL (1998) Acid–base. Lancet 352:474–479
Hess B (2006) Acid–base metabolism: implications for kidney stone formation. Urol Res 34:134–138
Rodríguez Soriano J (2002) Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 13:2160–2170
Domrongkitchaiporn S, Pongsakul C, Stitchantrakul W et al (2001) Bone mineral density and histology in distal renal tubular acidosis. Kidney Int 59:1068–1093
Osther PJ, Bollerslev J, Hansen AB, Engel K, Kildeberg P (1993) Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: evidence of disturbed calcium, bone and citrate metabolism. Urol Res 21:169–173
Weger W, Kotanko P, Weger M, Deutschmann H, Skrabal F (2000) Prevalence and characterization of renal tubular acidosis in patients with osteopenia and osteoporosis and in non-porotic controls. Nephrol Dial Transplant 15:975–980
Wrong O, Davies HEF (1959) The excretion of acid in renal disease. Quart J Med 28:259–313
Walsh SB, Shorley DG, Wrong OM, Unwin RJ (2007) Urinary acidification assessed by simultaneous furosemide and fludrocortisone treatment: an alternative to ammonium chloride. Kidney Int 71:1310–1316
Hess B, Michel R, Takkinen R, Ackermann D, Jaeger Ph (1994) Risk factors of low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to be added to the list. Nephrol Dial Transplant 9:642–649
Levey AS, Coresh J, Balk E et al (2003) National Kidney Foundation guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147
Arampatzis S, Röpke-Rieben B, Lippuner K, Hess B (2012) Prevalence and densitometric characteristics of incomplete distal renal tubular acidosis in men with recurrent calcium nephrolithiasis. Urol Res 40:53–59
Israni AK, Kasiske BL (2012) In: Taal ML et al. (eds) Brenner & Rector’s the kidney, chap. 25, Vol 1, 9th edn. Elsevier Saunders, Philadelphia, pp 868–896
Peacock M, Nordin BEC (1968) Tubular reabsorption of calcium in normal and hypercalciuric subjects. J Clin Pathol 21:353–358
Seeman E (2003) Physiology of aging-invited review: pathogenesis of osteoporosis. J Appl Physiol 95:2142–2151
Sornay-Rendu E, Boutroy S, Munoz F, Delmas P (2007) Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res 22:425–433
Pongchaiyakul C, Domrongkitchaiporn S, Stitchantrakul W, Chailurkit L, Rajatanavin R (2004) Incomplete renal tubular acidosis and bone mineral density: a population survey in an era of endemic renal tubular acidosis. Nephrol Dial Transplant 19:3029–3033
Fabris A, Bernich P, Abaterusso C, Marchionna N, Canciani C, Nouvenne A, Zamboni M, Lupo A, Gambaro G (2009) Bone disease in medullary sponge kidney and effect of potassium citrate treatment. Clin J Am Soc Nephrol 4:1974–1979
Gregory NS, Kumar R, Stein EM, Alexander E, Christos P, Bockman RS, Rodman JS (2015) Potassium citrate decrease bone resorption in postmenopausal women with osteopenia: a randomized, double- blind clinical trial. Edocr Pract 21:1380–1386
Dawson-Hughes B, Harris SS, Palermo NJ, Gilhooly CH, Shea MK, Fielding RA, Ceglia L (2015) Potassium bicarbonate supplementation lowers bone turnover and calcium excretion in older men and women: a randomized dose-finding trial. J Bone Miner Res 30:2103–2111
Jehle S, Hulter HN, Krapf R (2013) Effect of potassium citrate on bone density, microarchitectures, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab 98:207–217
Acknowledgments
We kindly thank R. Theiler, M.D., Zurich for critically reviewing the manuscript. The technical assistance of Kirsten Sitzmann and Sabine Matter in organizing and executing the study is greatly acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sromicki, J.J., Hess, B. Abnormal distal renal tubular acidification in patients with low bone mass: prevalence and impact of alkali treatment. Urolithiasis 45, 263–269 (2017). https://doi.org/10.1007/s00240-016-0906-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-016-0906-5